chevron_leftBack
As of 5 June 2026, PRF Technologies Ltd. has a market cap of $1.59M USD, ranking #47647 globally and #635 in Israel.
It ranks #4227 in the Healthcare sector, and #1339 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.59MUSD
Enterprise Value
-$2.52MUSD
Revenue (TTM)
$17.0KUSD
EBITDA (TTM)
-$4.35MUSD
Net Income (TTM)
-$4.84MUSD
PS Ratio
93.9
PB Ratio
0.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Efraim Cohen-Arazi
open_in_new
Employees
7
Founded
2007
IPO
01 Sep 2020
Website
painreform.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -7.8% | -24% | -6.7% | -47% | -70% | -83% |
News
Loading...
PRFX Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
PRFX
פיינרפורם בע”מ Ordinary Shares
ISIN: IL0011651580
Shares Out.:
Shares Outstanding:
844.372K1
Shares Float:
791.683K2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
1.88 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PRF Technologies Ltd.
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026. The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SLGL
|
$231.51M
14K%
|
-
|
|
NASDAQ: MDWD
|
$209.11M
13K%
|
-
|
|
TLV: EPIT
|
$87.73M
5K%
251.95M ILS
|
-
|
|
NASDAQ: PYPD
|
$86.83M
5K%
|
-
|
|
NASDAQ: ENTX
|
$52.68M
3K%
|
-
|
|
TLV: REKA
|
$46.66M
3K%
134.01M ILS
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
48M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
34M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
23M%
|
97.4
|
|
SIX: RO
|
$323.4B
20M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
18M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$276.26B
17M%
218.9B CHF
|
20.5
|
chevron_leftBack